Status:
COMPLETED
Mechanism and Intervention Research of Atherosclerosis
Lead Sponsor:
China National Center for Cardiovascular Diseases
Collaborating Sponsors:
Chinese Academy of Medical Sciences, Fuwai Hospital
Conditions:
Atherosclerosis
Eligibility:
All Genders
18+ years
Brief Summary
Patients with atherosclerosis are at high risk of future cardiovascular disease. Approximately 70% cardiac death and 50% myocardial infarction (MI) occurred among patients with established coronary ar...
Detailed Description
1. Organization of the project This project involves the cooperation between different teams. Principle investigator is responsible for all aspects of the project, including design, executive, monitor...
Eligibility Criteria
Inclusion
- Undergo elective coronary angiography in department of cardiology in period of study
- Written informed consent
Exclusion
- Age ≤18 years of age
- Unable to sign consent
- Other severe comorbidities with life expectancy \<1 year
Key Trial Info
Start Date :
January 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
30000 Patients enrolled
Trial Details
Trial ID
NCT05437107
Start Date
January 1 2017
End Date
December 31 2020
Last Update
June 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yuejin Yang
Beijing, Beijing Municipality, China, 100037